Beauty Health Cuts 2026 Revenue Guidance, Raises EBITDA Outlook
Beauty Health reported Q2 2026 revenue of approximately $72 million, at the lower end of guidance, and adjusted EBITDA of $17 million, above its guidance range. It lowered full-year revenue guidance to $280–$290 million and raised adjusted EBITDA guidance to $39–$46 million.